ResMed Inc. is a global company that develops, manufactures, and markets medical devices and cloud-connected software applications for the diagnosis and treatment of sleep apnea and other respiratory conditions.
Ticker code: ASX:RMD
Sector: Healthcare | Industry: Medical Instruments & Supplies | Website: https://www.resmed.co.in
Market Information
Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
---|---|---|---|---|
$62,179,170,673 | $5,821,069,312 | 1464150016 | 9.94 | $6,178,115,536 |
Balance Sheet & Quality
Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 24 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
---|---|---|---|---|---|---|
$59,690,469,746 | $1,209,449,984 | $851,812,992 | 23.3 | 33.6 | -0.6 | 43.0 |
Technicals & Short Data
3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
---|---|---|---|---|---|
Partial | 1.8 | $23,132,765 | $40,112,075 | 0.08 | 1.2 |
Dividends
Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
---|---|---|---|---|
$0.080 | $0.091 | None | 2025-08-13 | 0.4 |
Price Performance Snapshot
Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
---|---|---|---|---|---|---|
$42.270 | 0.2 | 1.6 | -2.7 | 9.0 | 20.1 | 15.3 |
ASX:RMD Price Chart with Volume and 3EMA

ASX:RMD Short Positions

Click HERE to understand why the above moving averages have been chosen.